[HTML][HTML] Eosinophilic fasciitis: from pathophysiology to treatment
H Ihn - Allergology International, 2019 - Elsevier
Eosinophilic fasciitis is a disease originally proposed as “diffuse fasciitis with eosinophilia”
by Shulman in 1974. The patients with this disease often have history of strenuous exercise …
by Shulman in 1974. The patients with this disease often have history of strenuous exercise …
Classical disease-specific autoantibodies in systemic sclerosis: clinical features, gene susceptibility, and disease stratification
C Yang, S Tang, D Zhu, Y Ding, J Qiao - Frontiers in medicine, 2020 - frontiersin.org
Systemic sclerosis (SSc) is an autoimmune disease characterized by abnormalities in
microcirculation, extracellular matrix accumulation, and immune activation. Autoantibodies …
microcirculation, extracellular matrix accumulation, and immune activation. Autoantibodies …
Identification of an Anti–Integrin αvβ6 autoantibody in patients with ulcerative colitis
T Kuwada, M Shiokawa, Y Kodama, S Ota, N Kakiuchi… - Gastroenterology, 2021 - Elsevier
Background and Aims Ulcerative colitis is the most frequent type of inflammatory bowel
disease and is characterized by colonic epithelial cell damage. Although involvement of …
disease and is characterized by colonic epithelial cell damage. Although involvement of …
Interleukin-17 pathway inhibition with brodalumab in early systemic sclerosis: Analysis of a single-arm, open-label, phase 1 trial
T Fukasawa, A Yoshizaki, S Ebata, M Fukayama… - Journal of the American …, 2023 - jaad.org
To the Editor: Systemic sclerosis (SSc) is an autoimmune disease that causes fibrosis of the
skin and internal organs, and a possible relationship exists between the activated interleukin …
skin and internal organs, and a possible relationship exists between the activated interleukin …
Eosinophilic fasciitis: current and remaining challenges
D Mazilu, LA Boltașiu, DA Mardale, MS Bijă… - International Journal of …, 2023 - mdpi.com
Eosinophilic fasciitis (EF), defined as diffuse fasciitis with eosinophilia by Shulman in 1974,
is a disease with unknown etiology and whose pathogenesis is still being researched. The …
is a disease with unknown etiology and whose pathogenesis is still being researched. The …
Esophageal dysfunction in systemic sclerosis: an update
B Li, J Yan, J Pu, J Tang, S Xu, X Wang - Rheumatology and Therapy, 2021 - Springer
Esophageal motility disorders are prevalent in 90% of patients with systemic sclerosis
[scleroderma (SSc)], with an increased mortality rate in patients with severe esophageal …
[scleroderma (SSc)], with an increased mortality rate in patients with severe esophageal …
Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival: a large cohort study of the German Network for …
P Moinzadeh, F Bonella, M Oberste, J Weliwitage… - Chest, 2024 - Elsevier
Background Pulmonary involvement is the leading cause of death in systemic sclerosis
(SSc) and may manifest as interstitial lung disease (ILD), pulmonary arterial hypertension …
(SSc) and may manifest as interstitial lung disease (ILD), pulmonary arterial hypertension …
Serum cold-inducible RNA-binding protein levels as a potential biomarker for systemic sclerosis-associated interstitial lung disease
I Omori, H Sumida, A Sugimori, M Sakakibara… - Scientific reports, 2023 - nature.com
Systemic sclerosis (SSc) is a complex autoimmune disease characterized by fibrotic,
inflammatory, and vascular dysfunction. Danger-associated molecular patterns (DAMPs) …
inflammatory, and vascular dysfunction. Danger-associated molecular patterns (DAMPs) …
Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotyping
H Tanaka, Y Okada, S Nakayamada… - Annals of the …, 2024 - ard.bmj.com
Objective Extracting immunological and clinical heterogeneity across autoimmune
rheumatic diseases (AIRDs) is essential towards personalised medicine. Methods We …
rheumatic diseases (AIRDs) is essential towards personalised medicine. Methods We …
Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: a prospective open-label study
R Pirrello, B Verro, G Grasso, P Ruscitti… - Arthritis Research & …, 2019 - Springer
Background Systemic sclerosis is a systemic connective tissue disease characterized by
endothelium damage, fibrosis, and subsequent atrophy of the skin. Perioral fibrosis …
endothelium damage, fibrosis, and subsequent atrophy of the skin. Perioral fibrosis …